Dexmedetomidine-esketamine combo may reduce delirium in ICU patients
A clinical trial is investigating the efficacy of a dexmedetomidine-esketamine combination to reduce delirium in ICU patients.
Asset / Drug
Drug and asset intelligence for dexmedetomidine with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.